Signaling Pathways - MDM2 - COX - Topoisomerases - D4 Receptors
清除全部
-
B1801 Norfloxacin中文名: 诺氟沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂 -
B1454 Rofecoxib中文名: 罗非昔布Target: COXSummary: COX-2抑制剂 -
B2293 Irinotecan HCl Trihydrate中文名: 盐酸依立替康三水合物Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B1459 Valdecoxib中文名: 代他考昔Target: COXSummary: COX-2抑制剂 -
B2235 Clozapine中文名: 氯氮平Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 ReceptorsSummary: 5-HT受体拮抗剂 -
B2290 Beta-Lapachone中文名: β-拉帕醌Target: TopoisomerasesSummary: 选择性DNA拓扑异构酶I抑制剂 -
A8400 Clinafloxacin CI96 AM1091中文名: 克林沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂 -
A8537 Thioridazine HCl中文名: 盐酸硫利达嗪，盐酸硫代利哒，甲硫达嗪盐酸盐，甲硫哒嗪盐酸盐Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 ReceptorsSummary: 钙通道蛋白抑制剂 -
A8503 Piroxicam中文名: 吡罗昔康Target: COX|Prostaglandin synthesisSummary: 前列腺素合成/Cox抑制剂 -
A8466 Meloxicam (Mobic)中文名: 美洛昔康Target: COXSummary: 非甾体抗炎药